Fulcrum Therapeutics, Inc. (NASDAQ:FULC) is held by 165 institutional investors per 13F filings through March 2026.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 6,561,111 | 0 | 0.00% | $50,323,721.00 |
| RA CAPITAL MANAGEMENT, L.P. | 31 Mar, 2026 | 6,053,960 | 0 | 0.00% | $46,433,873.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 5,390,593 | 1,126,832 | 26.43% | $41,345,848.00 |
| TCG Crossover Management, LLC | 31 Mar, 2026 | 5,250,000 | 0 | 0.00% | $40,267,500.00 |
| BRAIDWELL LP | 31 Mar, 2026 | 3,134,922 | 73,700 | 2.41% | $24,044,852.00 |
| Nantahala Capital Management, LLC | 31 Mar, 2026 | 3,050,040 | -1,243,306 | -28.96% | $23,393,807.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 2,692,948 | 2,692,948 | 0.00% | $20,654,911.00 |
| Siren, L.L.C. | 31 Mar, 2026 | 2,350,000 | 400,000 | 20.51% | $18,024,500.00 |
| First Turn Management, LLC | 31 Mar, 2026 | 2,256,109 | 363,426 | 19.20% | $17,304,356.00 |
| Aberdeen Group plc | 31 Mar, 2026 | 2,211,953 | 957,926 | 76.39% | $16,965,680.00 |
| Point72 Asset Management, L.P. | 31 Mar, 2026 | 2,074,855 | -323,377 | -13.48% | $15,914,138.00 |
| GSK plc | 31 Mar, 2026 | 1,785,714 | 0 | 0.00% | $13,696,426.00 |
| BALYASNY ASSET MANAGEMENT L.P. | 31 Mar, 2026 | 1,779,946 | 809,507 | 83.42% | $13,652,186.00 |
| Jones Hill Capital LP | 31 Mar, 2026 | 1,771,926 | 1,771,926 | 0.00% | $13,590,672.00 |
| D. E. Shaw & Co., Inc. | 31 Mar, 2026 | 1,623,281 | -290,474 | -15.18% | $12,450,565.00 |
| State Street Corp | 31 Mar, 2026 | 1,549,851 | 544,506 | 54.16% | $11,887,357.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 1,486,542 | 380,729 | 34.43% | $11,403,881.00 |
| Alyeska Investment Group, L.P. | 31 Mar, 2026 | 1,328,449 | 1,328,449 | 0.00% | $10,189,204.00 |
| CITADEL ADVISORS LLC | 31 Mar, 2026 | 1,292,486 | 85,482 | 7.08% | $9,913,368.00 |
| Assenagon Asset Management S.A. | 31 Mar, 2026 | 1,193,873 | 1,193,873 | 0.00% | $9,157,006.00 |